A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer

Purpose: Stage III non-small cell lung cancer (NSCLC) patients with poor performance status (PS) or co-morbidities are often not candidates for standard chemoradiotherapy (chemoRT) due to poor tolerance to treatments. A pilot study for poor-risk stage III NSCLC patients was conducted combining cetux...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuhchyau, Moon, James, Pandya, Kishan J., Lau, Derick H. M., Kelly, Karen, Hirsch, Fred R., Gaspar, Laurie E., Redman, Mary, Gandara, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755267/
https://www.ncbi.nlm.nih.gov/pubmed/24010120
http://dx.doi.org/10.3389/fonc.2013.00219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755267/
https://www.ncbi.nlm.nih.gov/pubmed/24010120
http://dx.doi.org/10.3389/fonc.2013.00219

Ejemplares similares